210 related articles for article (PubMed ID: 32979130)
1. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
2. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
4. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
7. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
[TBL] [Abstract][Full Text] [Related]
8. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
[TBL] [Abstract][Full Text] [Related]
10. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
Weingarten N; Kruser TJ; Bloch O
Clin Neurol Neurosurg; 2019 Apr; 179():14-18. PubMed ID: 30784894
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
[TBL] [Abstract][Full Text] [Related]
15. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
Yan M; Lee M; Myrehaug S; Tseng CL; Detsky J; Chen H; Das S; Yeboah C; Lipsman N; Costa LD; Holden L; Heyn C; Maralani P; Ruschin M; Sahgal A; Soliman H
J Neurooncol; 2023 Mar; 162(1):119-128. PubMed ID: 36914878
[TBL] [Abstract][Full Text] [Related]
17. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm.
Koide Y; Tomita N; Adachi S; Tanaka H; Tachibana H; Kodaira T
Nagoya J Med Sci; 2019 Aug; 81(3):397-406. PubMed ID: 31579330
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm).
Kawai Y; Aramaki S; Ishihara T; Suzuki K; Okawa T; Sato E; Ota N; Kosugi T; Amano M; Konishi K
Anticancer Res; 2023 Oct; 43(10):4543-4549. PubMed ID: 37772575
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]